SCHEMBL4254484

SCHEMBL4254484

NC(=O)c1oc2c(F)cc(F)cc2c1NC(=O)c1ccc(-c2cccc(CCl)c2)o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 4/20 0.42
GAA P10253 3/20 0.39
MGAM O43451 2/20 0.39
SI P14410 2/20 0.39
MGAM2 Q2M2H8 2/20 0.39
S1PR2 O95136 1/20 0.39
KMT2A Q03164 4/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SLC9A1 P19634 1/20 0.38
C3AR1 Q16581 2/20 0.38
NR4A1 P22736 1/20 0.37
NR4A2 P43354 1/20 0.37
NR4A3 Q92570 1/20 0.37
HSD17B10 Q99714 4/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPT P10636 3/20 0.37
MAPK10 P53779 3/20 0.37
TSHR P16473 3/20 0.37
ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4253039 0.89 S1PR4 (0.41) S1PR4GAAMGAMSIMGAM2
SCHEMBL13699829 0.88 S1PR4 (0.49) S1PR4GAAMGAMSIMGAM2
SCHEMBL13699897 0.85 MAPK10 (0.45) KMT2AHSD17B10MAPTMAPK10TSHR
SCHEMBL13700052 0.85 MAPT (0.39) GAAKMT2AHSD17B10KDM4EMAPT
SCHEMBL13699915 0.81 TP53 (0.50) KMT2AHSD17B10KDM4EMAPTMAPK10
SCHEMBL4255128 0.79 NPC1 (0.43) S1PR4S1PR2KMT2ANPC1RAB9A
SCHEMBL4253483 0.78 TP53 (0.42) S1PR4S1PR2KMT2AHSD17B10KDM4E
SCHEMBL13700081 0.78 L3MBTL1 (0.44) S1PR4GAAMGAMSIMGAM2
SCHEMBL4259581 0.77 MAPT (0.53) S1PR4S1PR2KMT2ANPC1RAB9A
SCHEMBL4256297 0.77 MAPK10 (0.61) GAAKMT2ANPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F S1PR4 1983/4885GAA 2532/4885MGAM 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.